Cargando…
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome
BACKGROUND: Cerebral ischaemia initiates an inflammatory response in the brain and periphery. We assessed the relationship between peak values of plasma interleukin-6 (IL-6) in the first week after ischaemic stroke, with measures of stroke severity and outcome. METHODS: Thirty-seven patients with is...
Autores principales: | Smith, Craig J, Emsley, Hedley CA, Gavin, Carole M, Georgiou, Rachel F, Vail, Andy, Barberan, Elisa M, del Zoppo, Gregory J, Hallenbeck, John M, Rothwell, Nancy J, Hopkins, Stephen J, Tyrrell, Pippa J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC331413/ https://www.ncbi.nlm.nih.gov/pubmed/14725719 http://dx.doi.org/10.1186/1471-2377-4-2 |
Ejemplares similares
-
Correction: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome
por: Smith, Craig J, et al.
Publicado: (2004) -
Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production
por: Emsley, Hedley CA, et al.
Publicado: (2007) -
Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence
por: McCulloch, Laura, et al.
Publicado: (2019) -
Feasibility of assessing the needs of stroke patients after six months using the GM-SAT
por: Rothwell, Katy, et al.
Publicado: (2013) -
Brain inflammation is induced by co-morbidities and risk factors for stroke
por: Drake, Caroline, et al.
Publicado: (2011)